Acute Hepatitis After Clozapine Administration: A Case Report and Review

References

• Kane J, Honigfeld G, Singer J, et al. Clozapine for the treatment‐resistant schizophrenic: a double‐blind comparison with chlorpromazine. Arch Gen Psychiatry 1988; 45: 789–796
   PubMed Web of Science ®Google Scholar
• Casey D E. Clozapine: neuroleptic‐induced EPS and tardive dyskinesia. Psychopharmacology 1989; 99: S47–S53
   PubMed Web of Science ®Google Scholar
• Ereshefsky L, Watanabe M D, Tran‐Johnson T K. Clozapine: an atypical antipsychotic. Clin Pharm 1989; 8: 691–709
   PubMedGoogle Scholar
• Leppig M, Bosch B, Naber D, et al. Clozapine in the treatment of 121 outpatients. Psychopharmacology 1989; 99: S77–S79
   Google Scholar
• Naber D, Leppig M, Grohmann R, et al. Efficacy and adverse effects of clozapine in die treatment of schizophrenia and tardive dyskinesia: a retrospective study of 387 patients. Psychopharmacology 1989; 99: S76–S82
   Google Scholar
• Gaertner H J, Fischer E, Hoss J. Side effects of clozapine. Psychopharmacology 1989; 99: S97–S100
   PubMed Web of Science ®Google Scholar
• Herning R I, Glover B J, Koeppl B. Frontal EEG asymmetry in cocaine abusers (abstract). Psycho‐physiology 1991; 28: S29
   Google Scholar
• Ritz M C, Lamb R J, Goldberg S R, et al. Cocaine receptors on dopamine transporters are related to self‐administration of cocaine. Science Sept., 1987; 4: 1219–1223
   Google Scholar
• Kanel G C, Cassidy W, Shuster L, et al. Cocaine‐induced liver cell injury: comparison of morphological features in man and in experimental animals. Hepatology 1990; 11: 646–651
   PubMed Web of Science ®Google Scholar
• Perino L E, Warren G H, Levine J S. Cocaine‐induced hepatotoxiciry in humans. Gastroenterology 1987; 93: 176–180
   PubMed Web of Science ®Google Scholar
• Donnelly D A, Boyer C S, Petersen D R, et al. Cocaine‐induced biochemical changes and cytotoxicity in hepatocytes isolated from both mice and rats. Chem Biol Interact 1988; 67: 95–104
   Google Scholar
• Altomare E, Vendemiale G, Albano O. Hepatic glutathione content in patients with alcoholic and nonalcoholic liver diseases. Life Sci 1988; 43: 991–998
   PubMedGoogle Scholar
• Lauterburg B H, Velez M E. Glutathione deficiency in alcoholics: risk factor for paracetamol hepatotoxiciry. Gut 1988; 29: 1153–1157
   PubMed Web of Science ®Google Scholar
• Boyer C S, Petersen D R. Potentiation of cocaine‐mediated hepatotoxicity by acute and chronic ethanol. Alcohol Clin Exp Res 1990; 14: 28–31
   Google Scholar
• Jewell S A, DiMonte D, Gentile A, et al. Decreased hepatic glutathione in chronic alcoholic patients. J Hepatol 1986; 3: 1–6
   PubMedGoogle Scholar
• Connors S, Rankin D R, Gandolfi A J, et al. Cocaine hepatotoxicity in cultured liver slices: a species comparison. Toxicology 1990; 61: 171–183
   PubMed Web of Science ®Google Scholar
• Comer G M, Mittal M K, Donelson S S, et al. Cluster of fulminant hepatitis B in crack users. Am J Gastroenterol 1991; 86: 331–334
   PubMed Web of Science ®Google Scholar
• Messiha F S. Extrapyramidal disorders: a possible underlying mechanism. Brain Res Bull 1983; 11: 233–241
   Google Scholar
• Meier‐Tackmann D, Korenke G C, Agarwal D P, et al. Human liver aldehyde dehydrogenase: subcellular distribution in alcoholics and nonalcoholics. Alcohol 1988; 5: 73–80
   PubMed Web of Science ®Google Scholar
• Freed E. Alcohol‐triggered, neuroleptic‐induced tremor, rigidity, and dystonia. Med J Aust 1981; 11: 44–45
   Google Scholar
• Lang A E, Marsden C D, Obeso J A, et al. Alcohol and Parkinson's disease. Ann Neurol 1982; 12: 254–258
   Google Scholar
• Carlen P L, Lee M A, Jacob M, et al. Parkinsonism provoked by alcoholism. Ann Neurol 1980; 9: 84–86
   Google Scholar
• Fischer V, Vogels B, Maurer G, et al. The antipsychotic clozapine is metabolized by the polymorphic human microsomal and recombinant cytochrome P‐450 2D6. J Pharmacol Exp Ther 1992; 260: 1355–1360
   PubMed Web of Science ®Google Scholar
• Linnet K, Andersen J R, Morup L. Liver function under long‐term treatment with neuroleptic drugs assessed by serum concentrations of bile acids, alkaline phosphatase, and aspartate aminotransferase. Acta Psychiatr Scand 1983; 67: 315–318
   Google Scholar
• Kellog E W I I I, Fridovich I. Superoxide, hydrogen peroxide, and singlet oxygen in lipid peroxidation by a xanthine oxidase system. J Biol Chem 1975; 250: 8812–8817
   PubMed Web of Science ®Google Scholar
• Helmstaedt D, May B. Liver disease in drug addicts: frequency, epidemiology, and social importance. Int J Clin Pharmacol 1975; 12: 46–47
   Google Scholar
• Rosenblatt H J, Eisenstein R, Baldwin D, et al. Nonviral hepatitis in drug addicts. Arch Pathol 1973; 95: 18–21
   Google Scholar
• Stimmel B, Vernace S, Tobias H. Hepatic dysfunction in heroin addicts: the role of alcohol. JAMA 1972; 222: 811–812
   PubMed Web of Science ®Google Scholar
• Kaplan K. Chronic liver disease in narcotics addicts. Am J Digest Dis 1963; 8: 402–410
   PubMedGoogle Scholar